CanSino Biologics Inc. (OTCMKTS:CASBF – Get Free Report) was the target of a large decrease in short interest during the month of October. As of October 15th, there was short interest totaling 11,640 shares, a decrease of 87.3% from the September 30th total of 91,840 shares. Based on an average daily trading volume, of 571 shares, the days-to-cover ratio is presently 20.4 days.
CanSino Biologics Stock Performance
Shares of OTCMKTS:CASBF opened at C$3.95 on Tuesday. The stock’s fifty day simple moving average is C$3.97 and its two-hundred day simple moving average is C$3.76. CanSino Biologics has a 1-year low of C$2.60 and a 1-year high of C$5.60.
CanSino Biologics Company Profile
CanSino Biologics Inc is a China-based biotechnology company focused on the research, development, manufacturing and commercialization of vaccines. The company develops vaccine technologies intended to address infectious diseases, with activities spanning early-stage research, clinical development, regulatory approval and commercial production.
CanSino’s portfolio includes Convidecia, an adenovirus-based COVID-19 vaccine, and Convidecia Air, an inhaled version designed for respiratory immunization.
Recommended Stories
- Five stocks we like better than CanSino Biologics
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for CanSino Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CanSino Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
